CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024		Mar. 31, 2023
Cash flows from operating activities
Net loss		$ (17,399)	[1],[2],[3]	$ (10,812)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization		4,258		3,117
Allowance for doubtful accounts	[1]	567
Provision for excess and obsolete inventories		2,882	[3]	293
Stock-based compensation		3,088		3,182
Change in fair value of financial instruments		(519)		517
Other		(785)		100
Changes in other assets and liabilities, net of acquisitions:
Accounts receivable		(3,099)		441
Inventories		(7,799)	[3]	(7,112)
Accounts payable		7,441		5,592
Accrued expenses		194		(877)
Accrued legal settlement				(9,000)
Income tax receivable/payable		340	[2]	132
Other assets and liabilities		(162)		367
Net cash used in operating activities		(10,993)		(14,060)
Cash flows from investing activities
Purchases of property and equipment		(5,817)		(7,521)
Proceeds from sale of property and equipment		292		223
Purchases of intangible assets		(253)		(254)
Net cash used in investing activities		(5,778)		(7,552)
Cash flows from financing activities
Payments on long-term debt		(160)		(197)
Payments of debt issuance costs				(7)
Proceeds from issuance of common stock, net of issuance costs				68,449
RSU vesting, taxes paid		(400)
Payments on earnout liability		(1,000)		(500)
Net cash used in financing activities		(1,262)		69,367
Effect of exchange rate changes on cash and cash equivalents		616		(340)
Net (decrease) increase in cash and cash equivalents		(17,417)		47,415
Cash and cash equivalents at beginning of period		75,639		38,468
Cash and cash equivalents at end of period		58,222		85,883
Supplemental disclosures of cash flow information:
Cash paid for interest		2,264		601
Purchase of property and equipment included in accounts payable		$ 4,952		$ 4,026

[1] Trade Receivable Reserve - The correction of the misstatement resulted in an increase to Selling, general and administrative of $567 for the three-months ended March 31, 2024.

[2] Income Tax Adjustment - The correction of the misstatement resulted in a decrease to Income tax expense (benefit) of $58 for the three-months ended March 31, 2024.

[3] Inventory Treatment - The correction of the misstatement resulted in an increase to Cost of goods sold of $1,656 for the three-months ended March 31, 2024.